08.30 – 10.30
Preventing CIED infection (state of the art implantation techniques, local and systemic
antibiotic prophylaxis, special precautions in high risk patients)
E. Soldati/ Pisa, Italy
Treatment of local and systemic CIED infection (duration of antibiotic treatment, role of
stand-alone antibiotic treatment, timing of extraction and reimplantation, treatment
of PM dependent patients during and after extraction)
J. Clancy/ New Haven, USA
Treatment results (device infection incidence, results of stand-alone antibiotic treatment
and lead extraction/antibiotic treatment, including complication rates)
J. Kautzner/ Prague, Czech Republic
11.00 – 13.00
Development, testing, trialing and approval of new leads
R. Canby / Austin, USA
A systematic approach to trouble-shooting leads
M. Cerini/ Brescia, Italy
Managing recalled and superfluous leads
L. Segreti / Pisa, Italy
Can all leads be made redundant in the future?
N. Linker/ Middlesbrough, UK
13.00 – 14.30
The evolution of transvenous ICD leads: from the Mirowski / Mower prototype to today
S. Nisam/ Brussels, Belgium
An independent review of the reliability data – registries, PPRs, indipendent studies
and how ICD leads really perform
E.W. Lau/ Belfast, UK
Has the transvenous ICD lead reached its zenith with new technologies such as
S-ICD and leadless pacemaker?
M.R. Gold/ Charleston, USA
Novel ICD lead development
A. Grace/ Cambridge, UK
Round Table: What can the implanter do to avoid lead extraction or to make it easier?
I. Anguera / Madrid, Spain –G. Zucchelli / Pisa, Italy – P.P. Mitkowski/ Poznan, Poland –
L. Van Erven/ Leiden, The Netherlands